IP Verse

Heterocyclic Compound

Patent No. EP3782986 (titled "Heterocyclic Compound") was filed by Takeda Pharmaceutical on Mar 28, 2019. The application was issued on Jul 10, 2024.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
DE CLERCQ & PARTNERSApr 10, 2025DE CLERCQ & PARTNERS

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3782986

TAKEDA PHARMACEUTICAL
Application Number
EP19774394A
Filing Date
Mar 28, 2019
Status
Granted And Under Opposition
Jun 7, 2024
Publication Date
Jul 10, 2024
External Links
Slate, Register , Google Patents